Core Insights - Tenon Medical, Inc. has successfully completed the first clinical procedures using its new SImmetry+ SI Joint Fusion System, marking a significant milestone in advancing treatment for sacro-pelvic disorders [1][5] - The SImmetry+ system is designed to provide a minimally invasive solution for SI joint fusion, incorporating 3D-printed titanium implants and established orthopedic fusion principles [2][4] - Initial use of the SImmetry+ system is part of a controlled early-access rollout, with feedback from experienced physicians to support broader commercial launch readiness [3][5] Product Overview - The SImmetry+ SI Joint Fusion System features a self-drilling, self-tapping, and self-harvesting design, allowing for flexible implantation with one to three implants based on patient needs [2] - Clinical evidence from the EvoluSIon study indicates a strong safety profile, with 68.7% of patients achieving radiographic fusion at 12 months and a 57.1% reduction in pre-operative opioid use [4] Strategic Positioning - The SImmetry+ system, along with the Catamaran SI Joint Fusion System, positions Tenon Medical with a multi-approach portfolio in the expanding sacro-pelvic market, enhancing its competitive advantage [5][6] - The company aims to customize treatment plans for patients through its innovative technologies, which are supported by robust clinical evidence [6] Company Background - Tenon Medical, Inc. was established in 2012 and has developed the Catamaran SI Joint Fusion System, which offers a less invasive approach to SI joint stabilization [7] - The company focuses on three commercial opportunities within the SI joint market: primary procedures, revision procedures, and augmenting spinal fusion [7]